Efficacy and safety of LY2963016 insulin glargine versus insulin glargine (Lantus) in Chinese adults with type 2 diabetes: A phase III,randomized, open-label,controlled trial |
| |
| Authors: | Wenhuan Feng PhD Wei Chen MD Shan Jiang PhD Liying Du MD Dalong Zhu PhD |
| |
| Affiliation: | 1. Department of Endocrinology, Drum Tower Hospital Affiliated to Nanjing University Medical School, Nanjing, China;2. Lilly (Shanghai) Management Co., Ltd, Shanghai, China;3. Lilly Suzhou Pharmaceutical Co., Ltd, Shanghai, China |
| |
| Abstract: | |
| |
| Keywords: | insulin glargine non-inferiority type 2 diabetes |
|
|
